Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Healthcare Company (ACHC) Invested Capital (2016 - 2025)

Historic Invested Capital for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to $3.1 billion.

  • Acadia Healthcare Company's Invested Capital rose 133.6% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year increase of 133.6%. This contributed to the annual value of $3.2 billion for FY2024, which is 1207.1% up from last year.
  • Acadia Healthcare Company's Invested Capital amounted to $3.1 billion in Q3 2025, which was up 133.6% from $3.1 billion recorded in Q2 2025.
  • Over the past 5 years, Acadia Healthcare Company's Invested Capital peaked at $3.2 billion during Q4 2024, and registered a low of $2.3 billion during Q1 2021.
  • Its 5-year average for Invested Capital is $2.8 billion, with a median of $2.8 billion in 2022.
  • The largest annual percentage gain for Acadia Healthcare Company's Invested Capital in the last 5 years was 2353.46% (2021), contrasted with its biggest fall of 1316.91% (2021).
  • Acadia Healthcare Company's Invested Capital (Quarter) stood at $2.5 billion in 2021, then grew by 11.75% to $2.8 billion in 2022, then decreased by 0.8% to $2.8 billion in 2023, then rose by 12.07% to $3.2 billion in 2024, then dropped by 0.19% to $3.1 billion in 2025.
  • Its Invested Capital was $3.1 billion in Q3 2025, compared to $3.1 billion in Q2 2025 and $3.1 billion in Q1 2025.